A detailed history of Pfg Investments, LLC transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Pfg Investments, LLC holds 10,000 shares of MCRB stock, worth $8,100. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,000
Previous 10,000 -0.0%
Holding current value
$8,100
Previous $7.24 Million 30.71%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$0.56 - $1.19 $12,008 - $25,517
-21,443 Reduced 68.2%
10,000 $7.24 Million
Q1 2024

Apr 22, 2024

BUY
$0.75 - $1.56 $14,957 - $31,111
19,943 Added 173.42%
31,443 $24.3 Million
Q4 2023

Jan 17, 2024

SELL
$0.93 - $2.15 $7,440 - $17,200
-8,000 Reduced 41.03%
11,500 $16.1 Million
Q2 2023

Aug 03, 2023

SELL
$4.67 - $6.55 $4,670 - $6,550
-1,000 Reduced 4.88%
19,500 $93.4 Million
Q1 2023

May 11, 2023

BUY
$4.95 - $6.09 $101,475 - $124,845
20,500 New
20,500 $116 Million

Others Institutions Holding MCRB

About Seres Therapeutics, Inc.


  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $100M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Pfg Investments, LLC Portfolio

Follow Pfg Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfg Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pfg Investments, LLC with notifications on news.